Amerikaanse financiën

Aktiemarkedet | Daglig Herald


Med den igangværende udvikling af et globalt salgsnetværk i de senere år har Haier Biomedical modtaget bred anerkendelse fra kunder, især på det amerikanske marked, og var stærkt begunstiget som den foretrukne leverandør af life science og biomedicinske løsninger.


Kyverna Therapeutics er en af ​​Haier Biomedicals vigtige kunder i USA. I første halvdel af året lukkede de $85 millioner serie B-finansiering. Overskuddet fra finansieringen vil blive brugt til at fremme de kliniske fase 2-forsøg med KYV-101, CAR-T-celleterapi for autoimmune sygdomme, der blev påbegyndt i første halvdel af året, og til at understøtte den fortsatte udvikling af den konstruerede T-celleterapi. “Jeg beundrede Haier Biomedicals virksomhedskultur meget, og Haier Biomedicals produkt gav Kyverna Therapeutics en stærk produktportefølje.” sagde Stefanie, Facility Director for Kyverna Therapeutics.



Different with Kyverna Therapeutics, Geltor is an American bio-design company that focuses on designing and producing high-performance protein products, but that doesn’t stop the team from loving Haier Biomedical’s energy-saving ultra-low temperature freezers.



“I never doubted its performance, and what surprises me more is its quiet operation and blue appearance, which always put me in a good mood when I’m working,” said Larry, Geltor’s Facility and Security Director.


Besides the above, Haier Biomedical’s ULT freezers were also widely used in the college, laboratory, government institutions to name but a few locations. The Johns Hopkins University in the United States has also introduced Haier Biomedical’s ULT freezer to provide a safe storage environment for scientific research samples.


Additionally, Haier Biomedical has also won the trust of US government agencies. The US Center for Disease Control has reached long-term cooperation with Haier Biomedical and signed a five-year procurement agreement, which further proves the recognition and trust of Haier Biomedical from international markets.


Haier Biomedical’s ULT freezer has reached the world-leading level in both performance and quality. Taking the ULT freezer DW-86L728J as an example, as a 728L model from the energy-saving series of Haier Biomedical’s ULT freezer, the product is designed with HC refrigerants, and its daily power consumption is down to 10.5kWh/24h only. The unique door seal design can minimize temperature loss even in the process of the door opening. Also, the base is designed to absorb vibration and sound, ensuring a quiet working environment. Professional and ergonomic design makes this product more and more favored by international users.


Da life science og teknologi fortsætter med at udvikle sig i et hurtigt tempo, fortsætter Haier Biomedical med at forblive på forkant med industriinnovation, og teamet stræber efter at opbygge lokaliseret globalt salgsnetværk og fortsætter med at insistere på “produkt + service”-modellen for at levere nøjagtige tjenester til brugerne. Haier Biomedical vil fortsætte med at fremme innovation, forskning og udvikling for konstant at udvide produktkategorier og bringe mere life science og biomedicinske produkter plus løsninger til verden for at gøre livet bedre.


Oprindelig kilde: https://www.haiermedical.com/news/HB-Products-Favored-by-the-US-Market.html


Source: https://finance.dailyherald.com/dailyherald/article/abnewswire-2022-9-17-hb-products-favored-by-the-us-market

Previous
Amerikaanse financiënRay Dalios medchef slog alarm om inflation, recession og en global finansiel boble i denne uge. Her er de 10 bedste citater.

Similar Posts

Leave a Reply